Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice

Andrey Shestakov, Håvard Jenssen, Robert E.W. Hancock, Inger Nordström, Kristina Eriksson

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


We have evaluated the potential of four synthetic peptides (denoted HH-2, 1002, 1006, 1018) with a distant relationship to the host defense peptide bovine bactenecin dodecapeptide for their ability to prevent genital infections with herpes simplex virus type 2 (HSV-2) in mice. All four peptides showed antiviral properties in vitro and reduced HSV-2 infection of Vero cells in a dose-dependent manner. Detailed analysis showed that the peptides were able to interfere with both viral attachment and entry, but not with replication post-entry, and were effective antivirals also when HSV-2 was introduced in human semen. Two of the peptides proved especially effective in reducing HSV-2 infection also in vivo. When admixed with virus prior to inoculation, both HH-2 and 1018 reduced viral replication and disease development in a genital model of HSV-2 infection in mice, and also when using very high infectious doses of HSV-2. These data show that peptides HH-2 and 1018 have antiviral properties and can be used to prevent genital herpes infection in mice.

Original languageEnglish
Pages (from-to)455-459
Number of pages5
JournalAntiviral Research
Issue number2
Publication statusPublished - 2013
Externally publishedYes


  • Antimicrobial peptides
  • Bovine bactenecin
  • Genital herpes
  • HSV-2
  • Synthetic analogues

ASJC Scopus subject areas

  • Pharmacology
  • Virology

Cite this